Anadys Pharmaceuticals

Carol G. Gallagher, Pharm. D., has been named vice president, commercial affairs, at Anadys Pharmaceuticals. Dr. Gallagher will be responsible for commercial affairs, including business development, market planning and strategic planning. “We are very pleased that Carol is joining Anadys,” said Kleanthis G. Xanthopoulos, Ph.D., Anadys’ president and chief executive officer. “Her leadership and experience in managing many therapeutic agents with multiple partners on a worldwide basis will be critical to Anadys as we build the foundation of our commercialization strategy.”

Prior to joining Anadys, Dr. Gallagher was the vice president, sales, marketing and product planning at CancerVax Corp. Previously, she was senior director of oncology marketing at Biogen Idec. During that time, her role included leadership of the Rituxan collaboration with Genentech. She also worked as director, global marketing planning for oncology and ophthalmology at Pfizer, and held other marketing positions, including product and new product management roles, at Agouron Pharmaceuticals, Lilly and Amgen.